XML 88 R25.htm IDEA: XBRL DOCUMENT v3.25.3

Licensing, Acquisitions and Other Arrangements (Tables)

9 Months Ended

Sep. 30, 2025

Licensing, Acquisitions, and Other Arrangements

Schedule of Research and Development Assets Acquired Other than Through Business Combination

The following table summarizes acquired IPR&D and milestones expense:

						Three months ended September 30,												Nine months ended September 30,
(in millions)						2025						2024						2025						2024
Upfront charges						$	2,615					$	82					$	3,566					$	1,088
Development milestones						65						—						185						95
Acquired IPR&D and milestones						$	2,680					$	82					$	3,751					$	1,183

X

- References

No definition available.

+ Details

Name:	abbv_AcquisitionsCollaborationsAndOtherArrangementsDisclosureAbstract
Namespace Prefix:	abbv_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of capitalized cost and amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-1

+ Details

Name:	us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration